REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteki Wrobel Smalec sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores
Full name: Apteki Wrobel Smalec sp. j. Profile Updated: May 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apteki Wrobel Smalec sp. j. is an enterprise based in Poland. Its main office is in Poznan. The enterprise currently operates in the Department Stores sector. It was established on August 07, 2018. There was a net sales revenue increase of 15.16% reported in Apteki Wrobel Smalec sp. j.’s latest financial highlights for 2023. Over the same period, its total assets decreased by 26.89%. The net profit margin of Apteki Wrobel Smalec sp. j. decreased by 0.05% in 2023.

Headquarters
Ul. Os. Piastowskie 75
Poznan; Wielkopolskie; Postal Code: 61-159

Contact Details: Purchase the Apteki Wrobel Smalec sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteki Wrobel Smalec sp. j. report to view the information.
Incorporation Date:
August 07, 2018
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteki Wrobel Smalec sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.16%
Total operating revenue
15.06%
Operating profit (EBIT)
9.75%
EBITDA
8.28%
Net Profit (Loss) for the Period
-17.92%
Total assets
-26.89%
Total equity
-13.77%
Operating Profit Margin (ROS)
0.26%
Net Profit Margin
-0.05%
Return on Equity (ROE)
0.42%
Debt to Equity Ratio
59.39%
Quick Ratio
-0.17%
Cash Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?